Spebrutinib
Spebrutinib (AVL-292; CC-292) is a covalent, orally active, and highly selective with an IC50 of 0.5 nM.
Product Specifications
CAS Number
[1202757-89-8]
Product Name Alternative
AVL-292; CC-292
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AVL-292.html
Purity
99.69
Solubility
DMSO : ≥ 45 mg/mL
Smiles
COCCOC1=CC=C(NC2=NC=C(F)C(NC3=CC=CC(NC(C=C)=O)=C3)=N2)C=C1
Molecular Formula
C22H22FN5O3
Molecular Weight
423.44
Precautions
H302, H315, H319, H335
References & Citations
[1]Evans EK, et al. Inhibition of Btk with CC-292 provides early pharmacodynamic assessment of activity in mice and humans. J Pharmacol Exp Ther. 2013 Aug;346 (2) :219-28.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![IL36 alpha (IL36A) Mouse Monoclonal Antibody [Clone ID: OTI3A12]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
